SCHEMBL13809243

SCHEMBL13809243

Cc1ccc(C(=O)N2CCc3cc4c(cc3C2c2cccc(Cl)c2Cl)OCO4)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.53
GRIN2C Q14957 2/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
GLA P06280 2/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2D6 P10635 1/20 0.38
GAA P10253 1/20 0.38
LMNA P02545 1/20 0.37
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
P2RX7 Q99572 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13809005 0.90 KIF11 (0.50) KIF11GRIN2CKMT2AKDM4EALDH1A1
SCHEMBL13809017 0.81 KIF11 (0.50) KIF11GRIN2CKMT2AMEN1KDM4E
SCHEMBL13809025 0.79 KIF11 (0.42) KIF11GRIN2CKMT2AMEN1KDM4E
SCHEMBL13809242 0.78 KIF11 (0.45) KIF11GRIN2CKMT2AKDM4EALDH1A1
SCHEMBL13748721 0.76 MEN1 (0.44) KIF11KMT2AMEN1KDM4EALDH1A1
SCHEMBL13809241 0.75 GRIN2C (0.41) GRIN2CKMT2AMEN1ALDH1A1LMNA
SCHEMBL10025892 0.75 P2RX7 (0.39) GRIN2CHCRTR1HCRTR2P2RX7
SCHEMBL13809015 0.74 KIF11 (0.45) KIF11GRIN2CKDM4EALDH1A1HPGD
SCHEMBL13809014 0.71 KIF11 (0.48) KIF11GRIN2CKDM4EALDH1A1HPGD
SCHEMBL11718509 0.69 KIF11 (0.59) KIF11GRIN2CKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009073545-A2 TETRAHYDRO-ISOQUINOLINE PPAT INHIBITORS AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 WO disclosed